HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

RPG Life Sciences Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 64 filings·Updated 30 Sept 2026
Showing 10 of 64 filings.
30 Sept 20261 filing
Company UpdateNewspaper Publication

Newspaper advertisement in respect to Special window opened for lodgment of transfer and dematerialization request(s).

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 16:40View Source
26 Sept 20261 filing
Company UpdateGeneral

RPG Active Pharma approves Scheme of Amalgamation with Actis Generics; approvals pending

Key amalgamation update

  • RPG Active Pharma Limited board approved a Scheme of Amalgamation with Actis Generics Private Limited.
  • Scheme subject to NCLT, RPG Active and Actis Generics shareholders approvals and other regulatory consents.
  • Transaction relates to transferor as wholly owned subsidiary; no share issue.
  • Related party transaction; MCA circular exemptions; not attract Section 188.
  • Aims to streamline structure, consolidate assets, improve oversight, and enhance capital deployment.
  • Upon scheme effectiveness, transferor shares held by transferee and nominees canceled.
  • No change in shareholding pattern upon effectiveness.
  • Transferor net worth INR 34.60 crore as of 31 Mar 2026; revenue INR 45.96 crore FY25-26.
  • Transferee net worth INR 34.75 crore as of 31 Mar 2026.
  • Approvals required: NCLT bench, RPG Active and Actis Generics shareholders, plus other authorities.
Filed 00:16View Source
25 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

RPG Life Sciences Ltd — Trading window closes from October 1, 2026 until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026

RPG Life Sciences Ltd — Trading window closes from October 1, 2026 until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026

Filed 17:51View Source
24 Sept 20262 filings
Company UpdateGeneral

RPG Life completes Actis Generics acquisition; Actis becomes subsidiary via RPG Active Pharma

Acquisition and subsidiary status

  • Completion of the acquisition of Actis Generics Private Limited by RPG Active Pharma Limited.
  • Actis Generics Private Limited becomes a subsidiary of RPG Active Pharma Limited.
  • Actis becomes a wholly owned subsidiary of RPG Active Pharma Limited and a subsidiary of RPG Life Sciences.
  • Effective date: September 24, 2026.
  • Transaction completed under the previously signed Share Purchase Agreement.
Filed 21:36View Source
Company UpdateClarification

The Exchange has sought clarification from RPG Life Sciences Ltd on September 24, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 12:13
23 Sept 20262 filings
Company UpdateSpurt in Volume

Significant increase in volume has been observed in RPG Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. RPG Life Sciences Limited has submitted their response.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:35View Source
Company UpdateSpurt in Volume

Significant increase in volume has been observed in RPG Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 18:00View Source
17 Sept 20261 filing
Company UpdateAnalyst / Investor Meet

RPG Life Sciences to hold Analyst/Institutional Investors meet on Sept 22, 2026 in Mumbai (physical)

Meeting Details

  • Date: September 22, 2026; Time: 10:00 AM IST onwards.
  • Meeting type/mode: Group meet and one-on-one; physical in Mumbai.
  • Host/Details: Anand Rathi G-200 Summit 2026.
  • Venue: Mumbai, physical.
  • Purpose: Analyst/Institutional Investors meet.
  • Company participants: not disclosed.
  • Presentation: will be available on company/stock exchange websites.
Filed 17:08View Source
15 Sept 20261 filing
Company UpdateGeneral

RPG Life Sciences completes slump sale transfer of API business to RPG Active Pharma, effective Sept 16, 2026

API business transfer completion

  • Transaction completed under BTA; RPG Active Pharma Limited to acquire API and intermediates business from Raghava Life Sciences.
  • Transfer of API business will be effective from September 16, 2026.
  • Transaction value not disclosed.
  • Expansion of API and intermediates portfolio for RPG Life Sciences.
Filed 23:30View Source
9 Sept 20261 filing
Company UpdateGeneral

ILSF and Vistaject Fund invest INR 243.33 crore for 40% of RPGAP; RPGAP remains subsidiary

Investment in RPG Active Pharma Limited

  • RPG Active Pharma Limited allotted securities to ILSF and Vistaject Fund for INR 243.33 crore.
  • This amount constitutes 40% of RPGAP's equity share capital.
  • Post-investment, RPGAP remains a subsidiary of RPG Life Sciences.
  • Investment completed on September 9, 2026.
Filed 22:50View Source
Showing 10 of 64 filings